Jeff Fairman - Net Worth and Insider Trading

Jeff Fairman Net Worth

The estimated net worth of Jeff Fairman is at least $25 Million dollars as of 2024-05-23. Jeff Fairman is the VP, Research of Vaxcyte Inc and owns about 353,370 shares of Vaxcyte Inc (PCVX) stock worth over $25 Million. Details can be seen in Jeff Fairman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeff Fairman has not made any transactions after 2022-10-26 and currently still holds the listed stock(s).

Transaction Summary of Jeff Fairman

To

Jeff Fairman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeff Fairman owns 1 companies in total, including Vaxcyte Inc (PCVX) .

Click here to see the complete history of Jeff Fairman’s form 4 insider trades.

Insider Ownership Summary of Jeff Fairman

Ticker Comapny Transaction Date Type of Owner
PCVX Vaxcyte Inc 2022-10-26 VP & Research

Jeff Fairman Latest Holdings Summary

Jeff Fairman currently owns a total of 1 stock. Jeff Fairman owns 353,370 shares of Vaxcyte Inc (PCVX) as of October 26, 2022, with a value of $25 Million.

Latest Holdings of Jeff Fairman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCVX Vaxcyte Inc 2022-10-26 353,370 71.36 25,216,483

Holding Weightings of Jeff Fairman


Jeff Fairman Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeff Fairman has made a total of 18 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Vaxcyte Inc is the sale of 10,000 shares on October 26, 2022, which brought Jeff Fairman around $400,000.

Insider Trading History of Jeff Fairman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeff Fairman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeff Fairman Ownership Network

Ownership Network List of Jeff Fairman

No Data

Ownership Network Relation of Jeff Fairman


Jeff Fairman Owned Company Details

What does Vaxcyte Inc do?

Who are the key executives at Vaxcyte Inc?

Jeff Fairman is the VP & Research of Vaxcyte Inc. Other key executives at Vaxcyte Inc include CFO & CBO Andrew Guggenhime , SVP & Gen Counsel & Corp Sec Mikhail Eydelman , and Chief Operating Officer Jim Wassil .

Vaxcyte Inc (PCVX) Insider Trades Summary

Over the past 18 months, Jeff Fairman made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 125,936 shares made by Grant Pickering , a net sale of 78,000 shares made by Andrew Guggenhime , and a net sale of 21,000 shares made by Jim Wassil .

In summary, during the past 3 months, insiders sold 80,244 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 80,244 shares. During the past 18 months, 281,265 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 281,265 shares.

Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vaxcyte Inc Insider Transactions

No Available Data

Jeff Fairman Mailing Address

Above is the net worth, insider trading, and ownership report for Jeff Fairman. You might contact Jeff Fairman via mailing address: C/o Vaxcyte, Inc., 825 Industrial Road, Ste. 300, San Carlos Ca 94070.

Discussions on Jeff Fairman

No discussions yet.